Abbott (ABT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $92.11 --0%
Revenue Growth %: +9.6%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +9.6%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.07 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.10-$5.20, versus the consensus of $5.16.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
- HawkEye 360 Pathfinder satellite model added to Air and Space Museum
- Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
